Downregulated miR-153 expression in glioma stem cells (GSCs) promotes its target gene, nuclear factor-erythroid 2-related factor-2 (Nrf-2), which cascades to activate GPX1 transcription and reduce ROS levels, resulting in further enhancement of the radioresistance and stemness in GSCs. The gene discussed is GPX1; the disease is central nervous system cancer.